Brandon Couillard
Stock Analyst at Wells Fargo
(4.44)
# 251
Out of 4,778 analysts
109
Total ratings
56.41%
Success rate
16.92%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Overweight | $415 → $420 | $368.63 | +13.94% | 3 | Feb 13, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Equal-Weight | $360 → $345 | $247.42 | +39.44% | 8 | Feb 12, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Equal-Weight | $360 → $345 | $265.82 | +29.79% | 8 | Feb 12, 2025 | |
| AVTR Avantor | Maintains: Overweight | $28 → $25 | $16.35 | +52.95% | 3 | Feb 10, 2025 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,350 → $1,400 | $1,195.74 | +17.08% | 3 | Feb 10, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $660 → $680 | $514.16 | +32.25% | 3 | Jan 31, 2025 | |
| DHR Danaher | Maintains: Equal-Weight | $280 → $240 | $212.48 | +12.95% | 2 | Jan 30, 2025 | |
| ALGN Align Technology | Maintains: Buy | $285 → $260 | $170.00 | +52.94% | 11 | Jan 23, 2025 | |
| HSIC Henry Schein | Maintains: Hold | $77 → $80 | $69.37 | +15.32% | 6 | Jan 23, 2025 | |
| CDNA CareDx | Upgrades: Equal-Weight | $28 → $24 | $19.06 | +25.92% | 2 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $157 → $155 | $120.50 | +28.63% | 20 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $85 | $45.67 | +86.12% | 16 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $75 | $43.24 | +73.45% | 2 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $34 → $75 | $100.73 | -25.54% | 2 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $35 | $9.74 | +259.34% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $180 | $141.95 | +26.81% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $2.31 | +333.84% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $120 | $125.42 | -4.32% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $130 | $107.41 | +21.03% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $17.46 | +31.77% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $0.92 | +1,312.43% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.49 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $2.94 | +274.15% | 2 | Oct 13, 2017 |
Waters
Feb 13, 2025
Maintains: Overweight
Price Target: $415 → $420
Current: $368.63
Upside: +13.94%
Bio-Rad Laboratories
Feb 12, 2025
Maintains: Equal-Weight
Price Target: $360 → $345
Current: $247.42
Upside: +39.44%
Bio-Rad Laboratories
Feb 12, 2025
Maintains: Equal-Weight
Price Target: $360 → $345
Current: $265.82
Upside: +29.79%
Avantor
Feb 10, 2025
Maintains: Overweight
Price Target: $28 → $25
Current: $16.35
Upside: +52.95%
Mettler-Toledo International
Feb 10, 2025
Maintains: Equal-Weight
Price Target: $1,350 → $1,400
Current: $1,195.74
Upside: +17.08%
Thermo Fisher Scientific
Jan 31, 2025
Maintains: Overweight
Price Target: $660 → $680
Current: $514.16
Upside: +32.25%
Danaher
Jan 30, 2025
Maintains: Equal-Weight
Price Target: $280 → $240
Current: $212.48
Upside: +12.95%
Align Technology
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $170.00
Upside: +52.94%
Henry Schein
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $69.37
Upside: +15.32%
CareDx
Jan 15, 2025
Upgrades: Equal-Weight
Price Target: $28 → $24
Current: $19.06
Upside: +25.92%
Dec 9, 2024
Maintains: Overweight
Price Target: $157 → $155
Current: $120.50
Upside: +28.63%
Nov 6, 2024
Maintains: Buy
Price Target: $84 → $85
Current: $45.67
Upside: +86.12%
Nov 6, 2024
Maintains: Overweight
Price Target: $78 → $75
Current: $43.24
Upside: +73.45%
Oct 30, 2024
Maintains: Equal-Weight
Price Target: $34 → $75
Current: $100.73
Upside: -25.54%
Aug 27, 2024
Initiates: Overweight
Price Target: $35
Current: $9.74
Upside: +259.34%
Aug 27, 2024
Initiates: Overweight
Price Target: $180
Current: $141.95
Upside: +26.81%
Aug 27, 2024
Initiates: Overweight
Price Target: $10
Current: $2.31
Upside: +333.84%
Aug 27, 2024
Initiates: Underweight
Price Target: $120
Current: $125.42
Upside: -4.32%
Aug 27, 2024
Initiates: Equal-Weight
Price Target: $130
Current: $107.41
Upside: +21.03%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $17.46
Upside: +31.77%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $0.92
Upside: +1,312.43%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $3.49
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $2.94
Upside: +274.15%